FIND YOUR CONSULTANT
JOIN OUR COMMUNITY
FIND YOUR CONSULTANT
JOIN OUR COMMUNITY

Industries > 

Life Sciences > CDMO/CRO & Life-science Tools Practice

CDMO/CRO & Life-science Tools Practice

Umbrex connects companies in CDMO/CRO & life-science tools practice to independent consultants with deep experience in the industry.

Over 90% of our CDMO/CRO & Life-science Tools Practice Practice consultants are alums of McKinsey, Bain, or BCG.

Finding the right consultant should be this easy.

1

Tell us about your project

2

Interview candidates

(We’ll provide bios within 48 hours on average)

3

Select your consultant and start work!

Find a consultant in our CDMO/CRO & Life-science Tools Practice

Prefer email? Write to [email protected]

Client Segments Umbrex Serves

  • Drug development CROs: Global CROs providing discovery, preclinical, and Phase I–IV services and FSP models; improve win rates, site performance, digital/AI trials, biometrics scale, and global delivery.
  • Life-science research tools and omics platforms: RUO instrument and reagent companies across sequencing, single‑cell, proteomics, and genome editing; scale installed base, consumables pull‑through, digital commerce, KOL influence, and channel partnerships.
  • Bioprocessing equipment and consumables suppliers: Suppliers of single‑use systems, bioreactors, media, resins, filtration, and sensors; drive platform adoption, OEM integrations, service models, supply resilience, and global manufacturing capacity.
  • Small‑molecule CDMOs: API and drug‑product CDMOs across oral solids and sterile injectables; optimize tech transfers, quality/compliance, capacity utilization, cost, digital QMS, and BD pipeline.
  • Biologics and advanced‑therapy CDMOs: Mammalian/microbial biologics, viral‑vector, plasmid, mRNA, and cell‑therapy manufacturers; build scalable CMC, MSAT, digital manufacturing, QA/QC, tech transfers, capacity strategy, and client acquisition globally.

Selected Capabilities of our CDMO/CRO & Life-science Tools Practice

Strategy & Corporate Development

  • Corporate Strategy And Long-Range Planning: Define ambition, value creation agenda, and five‑year plan for CDMO/CRO and tools; size TAM, modality trends, competitive position; set investment priorities, KPIs, and governance.
  • Modality And Service Line Strategy: Prioritize biologics, ADCs, oligonucleotides, cell and gene therapy, and mRNA across development, manufacturing, and analytics; define offerings, operating requirements, and unit economics to maximize margin.
  • Geographic Expansion And Market Entry: Prioritize countries and clusters; assess demand, regulatory, incentives, and talent; choose greenfield, JV, or acquisition; build entry roadmap and risk mitigations.
  • Mergers And Acquisitions Strategy And Commercial Diligence: Build M&A thesis and pipeline; conduct commercial, operational, and quality diligence; size synergies and risks; recommend valuation guardrails and deal structures for accretive growth.
  • Strategic Partnerships And Ecosystem Development: Secure preferred provider agreements, co‑development partnerships, and technology alliances; define monetization, exclusivity, governance; expand funnel, win rate, and share‑of‑wallet with biopharma and OEMs.

Operations

  • Tech Transfer And Scale-Up Acceleration: Standardize client‑to‑site tech transfer playbooks, critical‑to‑quality parameters, equipment fit, and master data; cut transfer cycle time and increase right‑first‑time in GMP manufacturing.
  • Throughput And Equipment Effectiveness Uplift: Deploy lean, quick changeover, and loss analysis on drug substance and fill‑finish; raise Overall Equipment Effectiveness, yield, and batches; reduce changeovers, COGS, and cycle time.
  • QC Lab Productivity And Release Velocity: Redesign sample flow, scheduling, and review‑by‑exception; optimize methods and analyst utilization; shrink quality control turnaround and batch release lead time for biologics and small molecules.
  • Finite Scheduling And Campaign Optimization: Implement constraint‑based scheduling for suites, single‑use systems, and cleaning; optimize campaign lengths and changeover windows; increase capacity utilization, service levels, and on‑time‑in‑full performance.
  • CRO Study Operations Excellence: Improve study start‑up, site activation, and risk‑based monitoring; streamline site contracts and source data verification levels; lift clinical research associate productivity and enrollment speed.

Supply Chain

  • Network And Warehousing Strategy: Design network and warehousing for Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and tools; define decoupling points, third‑party logistics, service parts depots; reduce cost‑to‑serve, lead times, on‑time‑in‑full risk.
  • Integrated Business Planning: Implement Integrated Business Planning linking bookings pipeline, study awards, demand, supply, and finance; embed Sales and Operations Planning (S&OP); improve forecast accuracy, service, and margin.
  • Materials Planning And Single Use Availability: Redesign material planning parameters, supplier schedules, and kitting for active pharmaceutical ingredients (APIs), excipients, single‑use assemblies, consumables; compress lead times, cut shortages, stabilize campaigns.
  • Clinical Trial Supply Chain Optimization: Design end‑to‑end clinical supply—forecasting, packaging, labeling, Interactive Response Technology setup, depot strategy; cut overage, stockouts, and country activation delays.
  • Inventory Optimization And Shelf Life Management: Deploy multi‑echelon inventory optimization with expiry‑aware buffers and allocation rules; reduce write‑offs, shortages, and working capital while protecting service levels.

Procurement & Strategic Sourcing

  • Category Strategy And Sourcing Waves: Develop category strategies for CDMOs and CROs covering resins, media, filters, single‑use, analytical services, and packaging; run sourcing waves; deliver savings, lead‑time reductions, and resilience.
  • Should Cost Modeling And Specification Harmonization: Build should‑cost models for single‑use assemblies, reagents, vials, and filters; harmonize specifications and catalogs across sites; reduce total cost of ownership and supply complexity.
  • Strategic Supplier Partnering And VMI Programs: Negotiate long‑term agreements with vendor managed inventory (VMI), consignment, and capacity reservations; embed change control and service levels; increase on‑time‑in‑full (OTIF), availability, and shortage resilience.
  • Clinical And Research Vendor Sourcing And Rate Cards: Source clinical and lab vendors—central lab, bioanalytical, electronic clinical outcome assessment, interactive response technology; standardize service agreements and rate cards; improve speed, quality, and cost.
  • Procurement Operating Model And Digital Enablement: Redesign procurement roles, governance, and playbooks; deploy eSourcing, contract lifecycle management, supplier risk and spend analytics; increase sourcing speed, compliance, and savings capture.

Product

  • Offering Portfolio And Service Productization: Productize CDMO and CRO services with defined deliverables, service level agreements (SLAs), and critical‑to‑quality (CTQ) attributes; speed quoting, reduce scope creep, and raise margins.
  • Platform Process Definition For Modalities: Define platform processes for monoclonal antibodies (mAbs), adeno‑associated virus (AAV), mRNA, and antibody‑drug conjugates (ADCs); set yield targets and templates; reduce tech transfer time, COGS.
  • Product Roadmap And Modular Architecture: Define instrument, software, and consumables roadmap with modular architecture and common subsystems; increase reuse, reduce bill of materials (BOM) cost, and accelerate time to market.
  • Voice Of Customer And Requirements Definition: Run Voice of Customer (VOC) and jobs‑to‑be‑done; translate into User Requirements Specifications (URS), Product Requirements Documents (PRD), and usability criteria; improve product‑market fit and adoption.
  • New Product Introduction And Lifecycle Governance: Redesign New Product Introduction (NPI) gates, design reviews, and change control; align R&D, manufacturing, and quality; reduce late changes, change cycle time, and launch risk.

Organization

  • Operating Model And Organizational Design: Design CDMO and CRO operating model across MSAT, QC, QA, manufacturing, and R&D; clarify decision rights and interfaces; reduce handoffs, rework, and cycle time.
  • Client Program Management And Governance Design: Define client program management roles, staffing model, RACI, escalation paths, and steering forums; improve on-time delivery, scope control, and client satisfaction.
  • Capability Building And Workforce Planning: Build capability maps and career architecture for MSAT, process engineering, aseptic operations, bioanalytical, and QA; plan hiring and upskilling; reduce vacancies, attrition, and overtime.
  • Global Shared Services And Centers Of Excellence: Stand up shared services and centers of excellence for quoting, tech transfer, master data, validation, and procurement; standardize processes; cut cost, cycle time, and errors.
  • Incentives And Performance Management: Redesign incentives, KPIs, and goal cascades aligned to utilization, throughput, right‑first‑time, OTIF, safety, and quality; increase accountability, productivity, and retention.

Pricing

  • Pricing Strategy And Commercial Model Design: Design value-based pricing and commercial models for CDMO/CRO and tools—fee‑for‑service, milestones, capacity reservations, expedite premiums, inflation indexation—to lift win rate and margin.
  • Rate Cards And Cost-To-Serve Pricing: Build standardized rate cards by service, modality, and geography with utilization and complexity premiums; align to cost‑to‑serve; improve transparency, margin, and comparability.
  • Configure Price Quote And Deal Desk Enablement: Deploy Configure Price Quote (CPQ) and deal desk with pricing rules, floors, approvals, and margin analytics; accelerate quoting, reduce leakage, and raise price realization across sites.
  • Contracting, Terms, And Escalation Governance: Standardize Master Service Agreement (MSA) and Statement of Work (SOW) pricing clauses—pass‑throughs, change orders, cancellation fees, indexation, raw material surcharges; enforce governance; protect margin and cash.
  • Instruments And Consumables Monetization Strategy: Design pricing for instruments, consumables, and software—bundles, reagent rental, subscriptions, tiered rebates, service level premiums; maximize pull‑through, recurring revenue, and customer lifetime value.

Sales

  • Account Segmentation And Coverage Design: Segment biopharma accounts by potential and modality; design territories, hunters/farmers, inside sales and Field Application Scientist (FAS) overlays; boost coverage, meetings, and qualified opportunities.
  • Key Account Management And Share-Of-Wallet Growth: Stand up key account management for top biopharma; map decision makers and sites, run account plans and governance; grow share‑of‑wallet, renewals, and multi‑site MSAs.
  • RFP Capture And Proposal Excellence: Systematize capture planning, win themes, technical solutioning, compliant RFP responses, and orals coaching; increase win rate, shorten sales cycles, and protect margin in CDMO/CRO pursuits.
  • Pipeline Management And Forecast Accuracy: Standardize stages, conversion metrics, and customer relationship management (CRM) hygiene; run weekly pipeline reviews and commit governance; improve forecast accuracy, hit rate, and bookings predictability.
  • Channel And Partner Sales Enablement: Design distributor, OEM, and integrator channels for tools; build partner programs, targets, and joint business planning; expand coverage, sell‑through, and new logos.

Finance

  • Bookings To Revenue Planning And Scenario Modeling: Build driver-based planning linking bookings to revenue via win rates, utilization, yields, start dates, and price; enable scenarios; improve forecast accuracy and margin visibility.
  • Project Accounting And ASC 606 Revenue Recognition: Redesign project accounting, milestones, estimates-to-complete, and variable consideration; implement ASC 606 revenue recognition; improve work-in-process (WIP) accuracy, revenue timing, backlog conversion, and earnings quality.
  • Costing And Profitability By Client Modality And Site: Establish standard costing and cost-to-serve analytics; allocate labor, materials, single-use, quality control (QC), and overhead; reveal profitability by client, program, modality, site, instrument, and channel.
  • Working Capital Optimization And Cash Forecasting: Optimize invoicing cadence, progress billing, collections, dispute management, inventory policies, and payables; implement 13-week cash forecasting; reduce days sales outstanding (DSO) and cash conversion cycle.
  • Capex Portfolio And Capital Allocation Governance: Set hurdle rates, stage gates, and benefits tracking; prioritize capacity expansions, single-use fleets, and labs; accelerate approvals and raise return on invested capital.

AI, Data & Analytics

  • Data Strategy And Lakehouse Architecture: Define data model and lakehouse integrating MES, LIMS, ERP, QMS, ELN, CRM, instrument IoT for CDMO/CRO; institute governance and lineage; unlock advanced analytics and AI.
  • Predictive Quality And Release Time Analytics: Apply multivariate SPC and anomaly detection on batch, sensor, and QC data; predict deviations and release dates; improve right-first-time and yield in CDMO/CRO manufacturing.
  • Commercial Analytics And Next-Best-Action For Sponsors: Build Customer 360 for biopharma sponsors and tools buyers; model win propensity and cross-sell; optimize next-best-action for CDMO/CRO BD; increase opportunities, hit rate, bookings.
  • Installed Base And Usage Analytics For Instruments: Ingest IoT telemetry from life-science instruments; model failure risk, consumables pull-through, and churn; drive predictive maintenance, parts availability, and recurring revenue growth.
  • MLOps And GxP Validation For AI: Establish MLOps with monitoring, documentation, access controls for machine learning and large language models; meet GxP validation and Computer Software Assurance; reduce drift and findings.

Transformation

  • Enterprise Performance Turnaround And EBITDA Uplift: Run cross‑functional sprints across CDMO/CRO tech transfer, manufacturing, QC, supply chain, and commercial; deliver EBITDA uplift via utilization, yield, OTIF improvement, mix, and SG&A reduction.
  • Transformation Office And Value Capture Management: Stand up a Transformation Office with governance, milestones, benefits tracking, and risk management; enforce cadence; accelerate value capture, backlog conversion, and on‑time delivery across sites.
  • Lean Production System And Digital At Scale: Deploy multi‑site Lean production system with tiered daily management, SMED, visual factory, and digital work instructions; raise OEE, right‑first‑time, and cycle time.
  • Quote-To-Cash And Delivery Transformation: Redesign quoting, tech transfer readiness, scheduling, and order‑to‑cash; integrate CPQ, PMO, and ERP workflows; cut lead time, cancellations, and revenue leakage; improve promise‑date accuracy.
  • Post-Merger Integration And Synergy Delivery: Plan and execute integrations or carve‑outs; harmonize processes, quality systems, and commercial policies; protect client service; deliver cost and revenue synergies, Day‑1 readiness, TSA exit.

Compliance

  • Enterprise Ethics And Compliance Program Design: Design ethics and compliance program for CDMO/CRO and tools—governance, policies, training, hotline, monitoring, investigations; reduce enforcement risk and embed compliant behaviors across sites.
  • Anti-Bribery, Third-Party Due Diligence, And Sanctions Compliance: Implement risk-based due diligence and monitoring per Foreign Corrupt Practices Act and UK Bribery Act; screen sanctions lists; control gifts and sponsorships; reduce corruption exposure.
  • Data Privacy And Clinical Data Protection Compliance: Design GDPR, HIPAA, and cross-border data transfer controls; enable de-identification, consent management, and Data Processing Agreements; protect patient data and reduce breach risk.
  • Trade Compliance And Export Controls Management: Stand up Export Administration Regulations (EAR), International Traffic in Arms Regulations (ITAR), and EU dual‑use compliance—classification, licensing, party screening, customs; minimize holds, fines, and disruption.
  • Controlled Substances And DEA Compliance: Design Drug Enforcement Administration quota, security, and recordkeeping controls; strengthen suspicious order monitoring and inventory reconciliation; avoid diversion, penalties, and production interruptions.

Program & Portfolio Management

  • Portfolio Governance And Prioritization: Establish portfolio governance and stage gates across client programs and CDMO/CRO initiatives; prioritize by risk‑adjusted margin, capacity impact, and strategic fit; increase throughput and productivity.
  • Enterprise PMO And Stage-Gate Delivery: Stand up an enterprise PMO; integrate tech transfer, PPQ, QC, supply milestones; enforce cadence and dependency management; improve on‑time‑in‑full delivery and cycle time.
  • Resource And Capacity Portfolio Planning: Model constrained suites, single‑use assets, labs, and talent; optimize allocation and sequencing across programs; cut bottlenecks, overtime, and lead time; maximize utilization and OTIF.
  • Backlog, Slot, And Promise Date Management: Centralize backlog and slot management across suites and labs; apply freeze windows and dynamic reoptimization; increase promise date accuracy, on‑time delivery, and revenue conversion.
  • Risk, Dependency, And Change Control: Implement standardized risk registers, dependency maps, and change control; run scenario playbooks; reduce delays, scope creep, and GMP compliance risk across the portfolio.

Information Technology

  • ERP Modernization And Project Manufacturing Enablement: Implement SAP S/4HANA or Oracle Cloud for project and process manufacturing; integrate quoting, WIP, serialization, rebates, revenue recognition; improve on‑time‑in‑full, visibility, and close speed.
  • MES And Electronic Batch Record Enablement: Deploy MES and Electronic Batch Records integrated with equipment, weigh‑dispense, and single‑use; enforce procedures and holds; boost right‑first‑time, release velocity, and audit readiness.
  • Laboratory Informatics Transformation: Implement LIMS, ELN, LES, and chromatography data systems; integrate instruments and master data; enable ALCOA+ integrity; cut QC turnaround, deviations, and batch release lead time.
  • Clinical Technology Stack Enablement: Deploy CTMS, eTMF, EDC integrations, and eCOA; automate study startup and governance; increase site activation speed, data quality, and sponsor transparency.
  • PLM And Digital Thread Enablement: Implement Product Lifecycle Management with CAD/PDM, requirements, and change control; integrate ERP and Quality Management System; accelerate NPI, traceability, and design‑to‑manufacturing handoffs for instruments and consumables.

Capital Projects

  • Front-End Loading And Basis Of Design: Define URS, capacity, biosafety, flows, utilities, and Basis of Design; build Class 3–4 estimates and schedules; de‑risk GMP scope, permits, cost, and approvals.
  • Flexible Single-Use And Modular Facility Delivery: Deploy modular cleanrooms and single‑use skids; design flexible suites for monoclonal antibodies (mAbs), viral vectors, oligos, and aseptic fill‑finish; compress schedule and startup risk.
  • Brownfield Expansion And Turnaround Management: Plan brownfield expansions, tie‑ins, and shutdowns; sequence utilities, biosafety, and construction around campaigns; minimize downtime, protect GMP operations, and accelerate capacity release.
  • EPC/EPCM Partner Strategy And Contracting: Select EPC/EPCM partners; structure target‑cost, guaranteed‑maximum‑price (GMP), and incentives; embed safety and quality KPIs; improve cost certainty, schedule adherence, and accountability.
  • Startup, Commissioning, And Operational Readiness: Coordinate Factory Acceptance Testing (FAT), Site Acceptance Testing (SAT), commissioning, turnover, training; integrate spares and calibration; accelerate operational readiness and Process Performance Qualification (PPQ) start.

Quality Management Systems

  • Quality System Design And Phase-Appropriate Harmonization: Design multi-site QMS aligned to GMP, GLP, and ISO 13485; harmonize SOPs, roles, and governance; enable scalability across modalities; reduce deviations and handoffs.
  • Deviation, CAPA, And Change Control Optimization: Standardize root cause, risk ranking, and effectiveness checks; streamline workflows and approvals; deploy dashboards; cut backlog, recurrence, and cycle time.
  • Quality Agreements And Audit Readiness: Author and harmonize Quality Agreements; prepare for sponsor audits and FDA/EMA inspections with mock audits, storyboards, and remediation; reduce observations, 483s, and findings.
  • Batch Record Review And Release Cycle Time Reduction: Implement review-by-exception, right-first-time coaching, and defect taxonomy; optimize interfaces with QC; shorten batch record review and release cycle time.
  • Supplier And Single-Use Quality Management: Segment and qualify suppliers; strengthen incoming inspection, lot release, and change control; govern single‑use assemblies and critical materials; improve OTIF, defect rates, and compliance.

Regulatory Affairs & Certifications

  • Instrument And IVD Regulatory Pathway Strategy: Define FDA 510(k)/De Novo/PMA and EU MDR/IVDR classifications, predicates, and evidence plans; align claims; de‑risk Notified Body reviews and compress time‑to‑approval.
  • Technical Documentation And CE/UKCA Marking Readiness: Author Technical Files/Design Dossiers with GSPR, risk, usability, performance evaluation, and PMS; manage Notified Body reviews; achieve CE/UKCA marking with fewer findings, faster certification.
  • DMF And CMC Contributor Enablement: Develop DMFs/ASMFs, Site Master Files, and CMC contributor packages; align controls and stability; enable sponsor submissions and faster client approvals.
  • Establishment Registration And Market Access Certifications: Stand up global establishment registration, product listing, GMP certificate upkeep, and country registrations; prevent lapsed certifications and import holds; ensure continuous market access.
  • Regulatory Information Management And UDI Governance: Design regulatory information management and UDI governance; standardize master data, GUDID/EUDAMED submissions, and change control; improve traceability, accuracy, and audit readiness.

Validation & Qualification

  • Validation Master Planning And Lifecycle Governance: Define Validation Master Plan (VMP) and risk‑based protocols per ASTM E2500 and EU Annex 15; clarify roles; raise inspection readiness and standardize validation.
  • Process Validation And Continued Process Verification: Design Process Performance Qualification (PPQ) strategy, sampling plans, and Continued Process Verification (CPV) dashboards; include aseptic simulations and hold‑time studies; reduce deviations and release delays.
  • Equipment And Utilities Qualification: Standardize Installation, Operational, and Performance Qualification (IQ/OQ/PQ) for critical equipment and Good Manufacturing Practice (GMP) utilities; define requalification triggers; improve uptime and compliance.
  • Cleaning Validation And Cross-Contamination Control: Develop Maximum Allowable Carryover (MACO) limits, worst‑case matrices, and swab/rinse methods; validate cleaning cycles and visual limits; reduce residues, cross‑contamination risk, and batch failures.
  • Analytical And Bioanalytical Method Validation And Transfer: Establish method validation and transfer protocols per International Council for Harmonisation Q2/Q14 for analytical and bioanalytical assays; harmonize criteria; cut out‑of‑specification rates and transfer time.
  • Validation Master Planning And Lifecycle Governance: Define Validation Master Plan (VMP) and risk‑based protocols per ASTM E2500 and EU Annex 15; clarify roles; raise inspection readiness and standardize validation.
  • Process Validation And Continued Process Verification: Design Process Performance Qualification (PPQ) strategy, sampling plans, and Continued Process Verification (CPV) dashboards; include aseptic simulations and hold‑time studies; reduce deviations and release delays.
  • Equipment And Utilities Qualification: Standardize Installation, Operational, and Performance Qualification (IQ/OQ/PQ) for critical equipment and Good Manufacturing Practice (GMP) utilities; define requalification triggers; improve uptime and compliance.
  • Cleaning Validation And Cross-Contamination Control: Develop Maximum Allowable Carryover (MACO) limits, worst‑case matrices, and swab/rinse methods; validate cleaning cycles and visual limits; reduce residues, cross‑contamination risk, and batch failures.
  • Analytical And Bioanalytical Method Validation And Transfer: Establish method validation and transfer protocols per International Council for Harmonisation Q2/Q14 for analytical and bioanalytical assays; harmonize criteria; cut out‑of‑specification rates and transfer time.

Connect with the right consultant

Umbrex rapidly connects you with independent professionals who combine top‑tier consulting experience at firms such as McKinsey, Bain, Boston Consulting Group with hands‑on roles.

Find a consultant in our CDMO/CRO & Life-science Tools Practice

Prefer email? Write to [email protected]